Concepedia

Extended-release Naltrexone

Extended-Release Naltrexone is a pharmaceutical formulation belonging to the class of opioid antagonist medications, distinguished by its sustained-release mechanism that provides prolonged blockade of opioid receptors to support relapse prevention in substance use disorders.

230

Publications

11.4K

Citations

856

Authors

325

Institutions

Publications per year

2017–2026

112

Variants

Xr-ntx

Parents

Publications

230

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial

Joshua D. Lee, Edward V. Nunes, Patricia Novo et al. · The Lancet · 2017 · 699 citations · Full text

, , +15

Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial

Evgeny Krupitsky, Edward V. Nunes, Walter Ling et al. · The Lancet · 2011 · 554 citations

, , +13

Injectable, Sustained-Release Naltrexone for the Treatment of Opioid Dependence

Sandra D. Comer, Maria A. Sullivan, Elmer Yu et al. · Archives of General Psychiatry · 2006 · 351 citations · Full text

, , +16

Development of a Cascade of Care for responding to the opioid epidemic

Arthur Robin Williams, Edward V. Nunes, Adam Bisaga et al. · The American Journal of Drug and Alcohol Abuse · 2019 · 335 citations · Full text

, , +17

Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population

Jake R. Morgan, Bruce R. Schackman, Jared A. Leff et al. · Journal of Substance Abuse Treatment · 2017 · 334 citations

, , +14

1–5 of 230

Authors

856

  1. EV
    Edward V. Nunes

    Columbia University, United States

    28 publications · 3.2K citations

    21

    h-index

  2. DR
    David R. Gastfriend

    Massachusetts General Hospital, United States

    18 publications · 1.3K citations

    16

    h-index

  3. JD
    Joshua D. Lee

    New York University, United States

    19 publications · 1.7K citations

    16

    h-index

  4. JR
    John Rotrosen

    New York University, United States

    16 publications · 1.6K citations

    14

    h-index

  5. CP
    Charles P. O’Brien

    University of Pennsylvania, United States

    15 publications · 1.1K citations

    14

    h-index

1–5 of 856

Institutions

325

  1. Johns Hopkins University

    Baltimore, United States

    21 h-index

    71 publications

    3.5K citations

  2. Johns Hopkins Medicine

    Baltimore, United States

    18 h-index

    65 publications

    3.1K citations

  3. Alkermes (United States)

    Waltham, United States

    18 h-index

    78 publications

    4.8K citations

  4. New York University

    New York, United States

    18 h-index

    108 publications

    9.1K citations

  5. Columbia University

    New York, United States

    17 h-index

    64 publications

    5.9K citations

  6. University of Pennsylvania

    Philadelphia, United States

    16 h-index

    75 publications

    2.7K citations

  7. Friends Research Institute

    Baltimore, United States

    15 h-index

    39 publications

    2.2K citations

  8. Yale University

    New Haven, United States

    14 h-index

    54 publications

    2.2K citations

1–8 of 325

Venues

  1. Journal of Substance Abuse Treatment

    35 publications · 1.3K citations

    19

    h-index

  2. Addiction

    16 publications · 860 citations

    16

    h-index

  3. Drug and Alcohol Dependence

    14 publications · 578 citations

    13

    h-index

  4. American Journal on Addictions

    8 publications · 226 citations

    9

    h-index

  5. Journal of Addiction Medicine

    JAM · 7 publications · 226 citations

    9

    h-index

1–5